Abstract:OBJECTIVE: Glioma has the highest incidence among the different tumor types within the nervous system, accounting for about 40% of them. Malignant glioma has a high invasion and metastasis rate, which leads to the poor prognosis of patients. By targeting specific genes, microRNAs serve as key regulators in the epithelial-mesenchymal transformation (EMT) process, which could provide new insights into the treatment of glioblastomas (GBM). The detailed molecular role that miR-623 plays in GBM still remains unclear.MATERIALS AND METHODS: The level of miR-623 in GBM cells was evaluated by RT-PCR. The function of miR-623 overexpression on GBM cell proliferation, migration, and invasion was assessed by MTS, Transwell analysis, and colony formation assay. In addition, a mouse subcutaneous xenograft model was used to study in vivo effects. The binding between miR-623 and TRIM44 was verified by a dual-luciferase reporter assay and the regulatory function of miR-623 on EMT markers was evaluated using Western blot.RESULTS: The expression of miR-623 was repressed in the GBM cancer cell lines. MiR-623 overexpression or TRIM44 knockdown attenuated the proliferation, migration, and invasion of GBM cell lines. TRIM44 could facilitate the reverse suppression of EMT and miR-623 in GBM progression. MiR-623 was found to inhibit TRIM44 expression by directly binding to its 3'UTR. In addition, systemic delivery of miR-623 mimic reduced tumor growth and inhibited TRIM44 protein expression in tumor-bearing nude mice. Furthermore, our findings indicated that miR-623 overexpression or TRIM44 down-regulation impeded the proliferation and migratory ability of LN229 and U251MG glioma cells, and miR-623 attenuates TRIM44-induced EMT by directly targeting the 3'UTR of TRIM44, which could serve as preliminary research to identify potential therapeutic targets for future treatment of GBM.CONCLUSION: Overall, microRNA-623 inhibits epithelial-mesenchymal transition to attenuate glioma proliferation by targeting TRIM44.

MicroRNA Interrelated Epithelial Mesenchymal Transition (EMT) in Glioblastoma

MicroRNA-Mediated Post-Transcriptional Regulation of Epithelial to Mesenchymal Transition in Cancer

MicroRNAs involved in the EGFR pathway in glioblastoma

MicroRNA in Human Glioma.

MicroRNA Enters Glioblastoma World

MicroRNAs as prognostic markers and therapeutic targets in gliomas

MicroRNAs Involved in Regulating Epithelial–mesenchymal Transition and Cancer Stem Cells As Molecular Targets for Cancer Therapeutics

MicroRNA-200b-3p Suppresses Epithelial-Mesenchymal Transition and Inhibits Tumor Growth of Glioma Through Down-Regulation of ERK5.

miRNAs role in glioblastoma pathogenesis and targeted therapy: Signaling pathways interplay

MicroRNA-623 Inhibits Epithelial–Mesenchymal Transition to Attenuate Glioma Proliferation by Targeting TRIM44

MicroRNA Expression Signatures and Their Correlation with Clinicopathological Features in Glioblastoma Multiforme

Role of MicroRNAs in Malignant Glioma

MicroRNAs Regulate Cell Cycle and Cell Death Pathways in Glioblastoma

MicroRNAs in Epithelial–Mesenchymal Transition Process of Cancer: Potential Targets for Chemotherapy

Use of microRNAs as Diagnostic, Prognostic, and Therapeutic Tools for Glioblastoma

Advance of MicroRNAs Research in Gliomas

EMT‐associated microRNAs and their roles in cancer stemness and drug resistance

The role of microRNA in the pathogenesis of glial brain tumors

Recent progress on the effects of microRNAs and natural products on tumor epithelial-mesenchymal transition.

Molecular mechanisms of microRNAs in regulating epithelial–mesenchymal transitions in human cancers

Unlocking the Potential of Circulating miRNAs as Biomarkers in Glioblastoma